Date | Time | Source | Headline | Symbol | Company |
07/18/2024 | 1:00PM | iHub Newswire | FeaturedNorth Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton | | |
07/08/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN to enhance the identification of human remains of Indigenous people and African Americans | NYSE:QGEN | Qiagen NV |
07/02/2024 | 9:29AM | GlobeNewswire Inc. | QIAGEN N.V. to release results for Q2 2024 and hold webcast | NYSE:QGEN | Qiagen NV |
06/27/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children | NYSE:QGEN | Qiagen NV |
06/17/2024 | 7:30AM | GlobeNewswire Inc. | QIAGEN announces 2028 strategy for solid profitable growth | NYSE:QGEN | Qiagen NV |
06/13/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs | NYSE:QGEN | Qiagen NV |
06/12/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth | NYSE:QGEN | Qiagen NV |
06/11/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance | NYSE:QGEN | Qiagen NV |
06/06/2024 | 4:50PM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:QGEN | Qiagen NV |
06/06/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period | NYSE:QGEN | Qiagen NV |
06/05/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe | NYSE:QGEN | Qiagen NV |
06/03/2024 | 2:00AM | GlobeNewswire Inc. | QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care | NYSE:QGEN | Qiagen NV |
05/31/2024 | 4:42PM | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NYSE:QGEN | Qiagen NV |
05/30/2024 | 5:55PM | GlobeNewswire Inc. | QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications | NYSE:QGEN | Qiagen NV |
05/30/2024 | 4:45PM | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NYSE:QGEN | Qiagen NV |
05/30/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications | NYSE:QGEN | Qiagen NV |
05/29/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine | NYSE:QGEN | Qiagen NV |
05/14/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support | NYSE:QGEN | Qiagen NV |
05/13/2024 | 2:00AM | GlobeNewswire Inc. | QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results | NYSE:QGEN | Qiagen NV |
05/07/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics | NYSE:QGEN | Qiagen NV |
05/02/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications | NYSE:QGEN | Qiagen NV |
04/29/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance | NYSE:QGEN | Qiagen NV |
04/24/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance | NYSE:QGEN | Qiagen NV |
04/09/2024 | 9:48AM | GlobeNewswire Inc. | QIAGEN N.V. to release results for Q1 2024 and hold webcast | NYSE:QGEN | Qiagen NV |
04/03/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024 | NYSE:QGEN | Qiagen NV |
03/25/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system | NYSE:QGEN | Qiagen NV |
03/18/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements | NYSE:QGEN | Qiagen NV |
03/11/2024 | 5:59AM | GlobeNewswire Inc. | QIAGEN announces Form 20-F annual report filing for 2023 results | NYSE:QGEN | Qiagen NV |
02/27/2024 | 5:44PM | GlobeNewswire Inc. | QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery | NYSE:QGEN | Qiagen NV |
02/27/2024 | 4:05PM | GlobeNewswire Inc. | QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification | NYSE:QGEN | Qiagen NV |